Cerner Corporation
4
104M
3
0.10
2
0.25
- Areas of investment
Summary
Cerner Corporation appeared to be the Corporate Investor, which was created in 1979. The main department of described Corporate Investor is located in the Kansas City. The venture was found in North America in United States.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Cerner Corporation, startups are often financed by BlueCross BlueShield Venture Partners, Kleiner Perkins, Camden Partners. The meaningful sponsors for the fund in investment in the same round are WuXi NextCODE, Cincinnati Childrenu2019s, Boston Children's Hospital.
The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2015. The common things for fund are deals in the range of more than 100 millions dollars.
The fund was created by Cliff Illig, Neal Patterson, Paul Gorup.
Among the most popular fund investment industries, there are Health Insurance, Hospital. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Claritas Genomics. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.
Investments analytics
Analytics
- Total investments
- 4
- Lead investments
- 2
- Rounds per year
- 0.10
- Follow on index
- 0.25
- Investments by industry
- Biotechnology (3)
- Health Care (3)
- Pharmaceutical (2)
- Medical (2)
- Information Technology (1) Show 6 more
- Investments by region
-
- United States (4)
- Peak activity year
- 2020
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Group Appearance index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Claritas Genomics | 26 Jan 2015 | Biotechnology, Hospital, Genetics, Children, Bioinformatics | Early Stage Venture | 15M | United States, Massachusetts, Cambridge |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.